Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

SUTAB

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

Standard Dose
0.225GM;0.188GM;1.479GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SUTAB is listed in Drugs@FDA under application 213135 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE Form and strength TABLET;ORAL - 0.225GM;0.188GM;1.479GM Sponsor AZURITY Submission history Latest submission status date: 2023-10-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview SUTAB is listed in Drugs@FDA under application 213135 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE Form and strength TABLET;ORAL - 0.225GM;0.188GM;1.479GM Sponsor AZURITY Submission history Latest submission status date: 2023-10-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.